PubRank

R L Hauger

Author PubWeight™ 71.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998 4.76
2 The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol 2013 2.48
3 Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 1999 1.87
4 Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics 2000 1.71
5 Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans. J Clin Endocrinol Metab 2000 1.71
6 Longitudinal analysis of multiple indicators of health decline among spousal caregivers. Ann Behav Med 1997 1.68
7 Effects of cholera and E. coli enterotoxins on cyclic adenosine 3',5'-monophosphate levels and intermediary metabolism in the thyroid. Endocrinology 1973 1.59
8 Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab 1997 1.56
9 Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry 2000 1.49
10 Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol Psychiatry 1996 1.45
11 Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med 1997 1.34
12 Circadian phase in adults of contrasting ages. Chronobiol Int 2005 1.21
13 Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry 1998 1.15
14 Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 2000 1.12
15 Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 1997 1.08
16 Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging 1996 1.07
17 Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology (Berl) 1992 1.04
18 Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 1993 1.02
19 N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J Neuroendocrinol 1999 1.00
20 Control of aldosterone secretion during sodium restriction: adrenal receptor regulation and increased adrenal sensitivity to angiotensin II. Proc Natl Acad Sci U S A 1978 0.97
21 A new concept for control of the estrous cycle of the ewe based on the temporal relationships between luteinizing hormone, estradiol and progesterone in peripheral serum and evidence that progesterone inhibits tonic LH secretion. Endocrinology 1977 0.97
22 Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry 2003 0.96
23 Plasma cortisol and neuropeptide Y in female victims of intimate partner violence. Psychoneuroendocrinology 2003 0.95
24 Molecular biology of the CRH receptors-- in the mood. Peptides 2001 0.95
25 Angiotensin II regulates its receptor sites in the adrenal glomerulosa zone. Nature 1978 0.92
26 The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile. J Neurochem 1999 0.91
27 Corticotropin-releasing factor receptors: distribution and regulation in brain, pituitary, and peripheral tissues. Ann N Y Acad Sci 1987 0.91
28 Specific [3H] beta-phenylethylamine binding sites in rat brain. Eur J Pharmacol 1982 0.91
29 GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation. Am J Physiol Regul Integr Comp Physiol 2001 0.90
30 Pituitary-adrenal axis responses to acute amphetamine in the rat. Pharmacol Biochem Behav 1993 0.90
31 Molecular Properties of the CRF Receptor. Trends Endocrinol Metab 2008 0.89
32 Brain and pituitary receptors for corticotropin releasing factor: localization and differential regulation after adrenalectomy. Peptides 1985 0.87
33 Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity. J Pharmacol Exp Ther 1990 0.87
34 Individual behavioral and neuroendocrine differences in responsiveness to audiogenic stress. Pharmacol Biochem Behav 1989 0.86
35 CRF activates autonomic nervous system and reduces natural killer cytotoxicity. Am J Physiol 1988 0.86
36 Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor. Peptides 1993 0.86
37 Distribution of corticotropin-releasing factor receptors in primate brain. Proc Natl Acad Sci U S A 1986 0.85
38 Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine. Neuropsychopharmacology 1998 0.84
39 Differential regulation of brain and pituitary corticotropin-releasing factor receptors by corticosterone. Endocrinology 1987 0.83
40 Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J Neuroendocrinol 1999 0.83
41 Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol Psychiatry 1997 0.83
42 Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides 2001 0.82
43 Stress: an overview of the literature with emphasis on job-related strain and intervention. Adv Ther 1995 0.81
44 Hypothalamic-pituitary-adrenal axis function in the Zucker obese rat. Endocrinology 1992 0.81
45 Aging effects on the startle response and startle plasticity in Fischer F344 rats. Neurobiol Aging 1998 0.81
46 G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology 2001 0.80
47 Characteristics of [3H](+)-amphetamine binding sites in the rat central nervous system. Life Sci 1984 0.80
48 Hormonal responses to d- and d,l-fenfluramine in healthy human subjects. Neuropsychopharmacology 1996 0.80
49 A sex-related pattern of gonadotropin secretion in the castrated rat: effects of changing the inhibitory steroid or pituitary LH content. Biol Reprod 1977 0.80
50 Neuropeptide Y radio-immunoassay: characterization and application. Clin Exp Pharmacol Physiol 1991 0.80
51 Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system. Neuroendocrinology 1986 0.80
52 A multivariate twin study of hippocampal volume, self-esteem and well-being in middle-aged men. Genes Brain Behav 2012 0.79
53 Negative feedback action of progesterone on tonic luteinizing hormone secretion in the ewe: dependence on the ovaries. Endocrinology 1977 0.79
54 Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. Int Clin Psychopharmacol 1995 0.79
55 Prolactin response to D-fenfluramine in outpatients with major depression. Psychiatry Res 1998 0.79
56 Pituitary regulation of Leydig cell function in the adult male rat. J Endocrinol 1977 0.79
57 Characterization of angiotensin II receptors in the anterior pituitary gland. Mol Cell Endocrinol 1982 0.78
58 The neurosteroid allopregnanolone modulates oxytocin expression in the hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 2000 0.78
59 Sympathetic alterations after sodium restriction and short-term captopril administration. J Am Coll Cardiol 1993 0.77
60 Changes in brain corticotropin-releasing factor messenger RNA expression in aged Fischer 344 rats. Brain Res 1999 0.77
61 Central corticotropin releasing factor reduces natural cytotoxicity. Time course of action. Neuropsychopharmacology 1989 0.77
62 The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology (Berl) 2013 0.76
63 Glucostatic regulation of (+)-[3H]amphetamine binding in the hypothalamus: correlation with Na+,K+-ATPase activity. Proc Natl Acad Sci U S A 1985 0.76
64 Testicular receptors for luteinizing hormone after immunoneutralization of gonadotrophin releasing hormone in the male rat. J Endocrinol 1977 0.76
65 Adaptation to chronic stress. Temporal pattern of immune and neuroendocrine correlates. Neuropsychopharmacology 1988 0.76
66 Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia. Psychiatry Res 1996 0.76
67 Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors. Biol Psychiatry 1999 0.76
68 Cortisol and growth hormone responses to the 5-HT1A agonist gepirone in depressed patients. Biol Psychiatry 1990 0.76
69 Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers. Psychoneuroendocrinology 1997 0.76
70 TSH response to TRH and family history of alcoholism. Biol Psychiatry 1990 0.75
71 Dopaminergic denervation increases [3H](+)-amphetamine binding in the rat striatum. Eur J Pharmacol 1985 0.75
72 Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers. Clin Neuropharmacol 1993 0.75
73 Steroidal regulation of portal arginine-vasopressin levels in aged Fischer 344 rats. Brain Res 1999 0.75
74 Benzodiazepines antagonize central corticotropin releasing hormone-induced suppression of natural killer cell activity. Brain Res 1993 0.75
75 Response of three hormones to diazepam challenge in sons of alcoholics and controls. Alcohol Clin Exp Res 1991 0.75
76 Glucostatic regulation of hypothalamic and brainstem [3H](+)-amphetamine binding during food deprivation and refeeding. Eur J Pharmacol 1986 0.75
77 Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration. Psychiatry Res 1995 0.75
78 The effect of clorgyline on noradrenergic function. Psychopharmacology (Berl) 1985 0.75
79 Regulation of the anorectic drug recognition site during glucoprivic feeding. Brain Res Bull 1992 0.75